NT-proBNP Predicts All-Cause Mortality in a Population of Insurance Applicants, Follow-up Analysis and Further Observations.

J Insur Med

Michael Fulks, Clinical Reference Laboratory, Jackson, CA; Valerie Kaufman, RGA Reinsurance Company, Chesterfield, MO; Michael Clark, Penn Mutual Life Insurance Company, Horsham, PA; Robert L. Stout, Clinical Reference Laboratory, Lenexa, KS.

Published: January 2019

Objective: - Further refine the independent value of NT-proBNP, accounting for the impact of other test results, in predicting all-cause mortality for individual life insurance applicants with and without heart disease.

Method: - Using the Social Security Death Master File and multivariate analysis, relative mortality was determined for 245,322 life insurance applicants ages 50 to 89 tested for NT-proBNP (almost all based on age and policy amount) along with other laboratory tests and measurement of blood pressure and BMI.

Results: - NT-proBNP values ≤75 pg/mL included the majority of applicants denying heart disease and had the lowest risk, while values >500 pg/mL for females and >300 pg/mL for males had very high relative risk. Those admitting to heart disease had a higher mortality risk for each band of NT-proBNP relative to those denying heart disease but had a similar and equally predictive risk curve.

Conclusion: - NT-proBNP is a strong independent predictor of all-cause mortality in the absence or presence of known heart disease but the range of values associated with increased risk varies by sex.

Download full-text PDF

Source
http://dx.doi.org/10.17849/insm-47-02-107-113.1DOI Listing

Publication Analysis

Top Keywords

heart disease
16
all-cause mortality
12
insurance applicants
12
life insurance
8
denying heart
8
nt-probnp
6
mortality
5
heart
5
risk
5
nt-probnp predicts
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!